XML 31 R16.htm IDEA: XBRL DOCUMENT
v3.22.2.2

Organization, Basis of Presentation and Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2022
Accounting Policies [Abstract] |
Schedule of Fair Value And Amortized Cost of Marketable Securities | The fair value and amortized cost of marketable securities by major security type is as follows:
|  | September 30, 2022 |
(in thousands) |  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
Money market funds |  | $ | 37,094 |  |  | $ | — |  |  | $ | — |  |  | $ | 37,094 |
U.S. government securities |  |  | 43,120 |  |  |  | — |  |  |  | (681 | ) |  |  | 42,439 |
Non-U.S. government securities |  |  | 3,022 |  |  |  | — |  |  |  | (41 | ) |  |  | 2,981 |
Corporate debt securities |  |  | 29,514 |  |  |  | — |  |  |  | (284 | ) |  |  | 29,230 |
Commercial paper |  |  | 49,659 |  |  |  | — |  |  |  | — |  |  |  | 49,659 |
Total |  | $ | 162,409 |  |  | $ | — |  |  | $ | (1,006 | ) |  | $ | 161,403 |
Classified as: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  |  |  |  |  | $ | 37,094 |
Marketable securities |  |  |  |  |  |  |  |  |  |  |  | 124,309 |
Total |  |  |  |  |  |  |  |  |  |  | $ | 161,403 |
|  | December 31, 2021 |
(in thousands) |  | Amortized Cost |  |  | Unrealized Gains |  |  | Unrealized Losses |  |  | Fair Value |
Money market funds |  | $ | 33,239 |  |  | $ | — |  |  | $ | — |  |  | $ | 33,239 |
U.S. government securities |  |  | 36,322 |  |  |  | — |  |  |  | (130 | ) |  |  | 36,192 |
Non-U.S. government securities |  |  | 11,194 |  |  |  | — |  |  |  | (12 | ) |  |  | 11,182 |
Corporate debt securities |  |  | 39,495 |  |  |  | — |  |  |  | (52 | ) |  |  | 39,443 |
Commercial paper |  |  | 31,466 |  |  |  | — |  |  |  | — |  |  |  | 31,466 |
Total |  | $ | 151,716 |  |  | $ | — |  |  | $ | (194 | ) |  | $ | 151,522 |
Classified as: |  |  |  |  |  |  |  |  |  |  |  |
Cash equivalents |  |  |  |  |  |  |  |  |  |  | $ | 33,239 |
Marketable securities |  |  |  |  |  |  |  |  |  |  |  | 118,283 |
Total |  |  |  |  |  |  |  |  |  |  | $ | 151,522 |
Schedule of Accrued Expenses and Other Current Liabilities | Accrued expenses and other current liabilities included the following:
(in thousands) |  | September 30, 2022 |  |  | December 31, 2021 |
Research and development costs |  | $ | 1,559 |  |  | $ | 1,570 |
Compensation and benefit costs |  |  | 1,993 |  |  |  | 2,403 |
Accrued professional fees |  |  | 862 |  |  |  | 363 |
Other |  |  | 308 |  |  |  | 358 |
Total accrued expenses and other current liabilities |  | $ | 4,722 |  |  | $ | 4,694 |
Schedule of Antidilutive Securities Excluded from Computation of Net Loss per Share | The Company excluded the following potential shares of common stock, presented based on amounts outstanding at each period end, from the computation of diluted net loss attributable to common stockholders per share of common stock for the periods indicated because including them would have had an anti-dilutive effect:
|  | September 30, |
|  | 2022 |  |  | 2021 |
Options to purchase common stock |  |  | 4,760,085 |  |  |  | 3,556,043 |
Unvested restricted stock units |  |  | 100,880 |  |  |  | — |
Shares issuable under employee stock purchase plan |  |  | 112,757 |  |  |  | — |
Total |  |  | 4,973,722 |  |  |  | 3,556,043 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration